GTBIF
Price
$8.27
Change
+$0.36 (+4.55%)
Updated
Sep 5 closing price
Capitalization
1.92B
TSNDF
Price
$0.85
Change
+$0.10 (+13.33%)
Updated
Sep 5 closing price
Capitalization
264.18M
73 days until earnings call
Interact to see
Advertisement

GTBIF vs TSNDF

Header iconGTBIF vs TSNDF Comparison
Open Charts GTBIF vs TSNDFBanner chart's image
Green Thumb Industries
Price$8.27
Change+$0.36 (+4.55%)
Volume$211.33K
Capitalization1.92B
TerrAscend
Price$0.85
Change+$0.10 (+13.33%)
Volume$676.24K
Capitalization264.18M
GTBIF vs TSNDF Comparison Chart in %
Loading...
GTBIF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
TSNDF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
GTBIF vs. TSNDF commentary
Sep 06, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is GTBIF is a Hold and TSNDF is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 06, 2025
Stock price -- (GTBIF: $8.27 vs. TSNDF: $0.85)
Brand notoriety: GTBIF and TSNDF are both not notable
Both companies represent the Pharmaceuticals: Generic industry
Current volume relative to the 65-day Moving Average: GTBIF: 29% vs. TSNDF: 84%
Market capitalization -- GTBIF: $1.92B vs. TSNDF: $264.18M
GTBIF [@Pharmaceuticals: Generic] is valued at $1.92B. TSNDF’s [@Pharmaceuticals: Generic] market capitalization is $264.18M. The market cap for tickers in the [@Pharmaceuticals: Generic] industry ranges from $67.95B to $0. The average market capitalization across the [@Pharmaceuticals: Generic] industry is $3.93B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

GTBIF’s FA Score shows that 1 FA rating(s) are green whileTSNDF’s FA Score has 1 green FA rating(s).

  • GTBIF’s FA Score: 1 green, 4 red.
  • TSNDF’s FA Score: 1 green, 4 red.
According to our system of comparison, both GTBIF and TSNDF are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

GTBIF’s TA Score shows that 4 TA indicator(s) are bullish while TSNDF’s TA Score has 4 bullish TA indicator(s).

  • GTBIF’s TA Score: 4 bullish, 5 bearish.
  • TSNDF’s TA Score: 4 bullish, 5 bearish.
According to our system of comparison, GTBIF is a better buy in the short-term than TSNDF.

Price Growth

GTBIF (@Pharmaceuticals: Generic) experienced а -4.83% price change this week, while TSNDF (@Pharmaceuticals: Generic) price change was -26.03% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Generic industry was +0.08%. For the same industry, the average monthly price growth was +12.00%, and the average quarterly price growth was +86.48%.

Reported Earning Dates

TSNDF is expected to report earnings on Nov 18, 2025.

Industries' Descriptions

@Pharmaceuticals: Generic (+0.08% weekly)

A generic drug contains the same chemical substance as a drug that was originally protected by patents. Generic drugs are generally sold at cheaper price points, compared to name-brand pharmaceuticals, after patents for the more expensive drugs lapse. The generic drug industry has created a major market, thanks to the lower pricing. According to the Center for Justice and Democracy at New York Law School, 80 percent of all drugs prescribed are generic, and generic drugs are chosen 94 percent of the time when they are available. But their manufacturers must be able to prove to the FDA that they can be effective substitutes for the original drugs. Some of the major generic drug makers include Zoetis, Inc., Allergan plc and Mylan N.V.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
GTBIF($1.92B) has a higher market cap than TSNDF($264M). TSNDF has higher P/E ratio than GTBIF: TSNDF (85.07) vs GTBIF (75.18). TSNDF YTD gains are higher at: 30.877 vs. GTBIF (1.224). GTBIF has higher annual earnings (EBITDA): 338M vs. TSNDF (11.3M). GTBIF has more cash in the bank: 177M vs. TSNDF (27.7M). TSNDF has less debt than GTBIF: TSNDF (242M) vs GTBIF (523M). GTBIF has higher revenues than TSNDF: GTBIF (1.15B) vs TSNDF (300M).
GTBIFTSNDFGTBIF / TSNDF
Capitalization1.92B264M728%
EBITDA338M11.3M2,991%
Gain YTD1.22430.8774%
P/E Ratio75.1885.0788%
Revenue1.15B300M385%
Total Cash177M27.7M639%
Total Debt523M242M216%
FUNDAMENTALS RATINGS
GTBIF vs TSNDF: Fundamental Ratings
GTBIF
TSNDF
OUTLOOK RATING
1..100
6923
VALUATION
overvalued / fair valued / undervalued
1..100
85
Overvalued
77
Overvalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
9198
PRICE GROWTH RATING
1..100
4335
P/E GROWTH RATING
1..100
98
SEASONALITY SCORE
1..100
n/a50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TSNDF's Valuation (77) in the null industry is in the same range as GTBIF (85). This means that TSNDF’s stock grew similarly to GTBIF’s over the last 12 months.

TSNDF's Profit vs Risk Rating (100) in the null industry is in the same range as GTBIF (100). This means that TSNDF’s stock grew similarly to GTBIF’s over the last 12 months.

GTBIF's SMR Rating (91) in the null industry is in the same range as TSNDF (98). This means that GTBIF’s stock grew similarly to TSNDF’s over the last 12 months.

TSNDF's Price Growth Rating (35) in the null industry is in the same range as GTBIF (43). This means that TSNDF’s stock grew similarly to GTBIF’s over the last 12 months.

TSNDF's P/E Growth Rating (8) in the null industry is in the same range as GTBIF (9). This means that TSNDF’s stock grew similarly to GTBIF’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
GTBIFTSNDF
RSI
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
90%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
81%
Bullish Trend 2 days ago
79%
Momentum
ODDS (%)
Bearish Trend 2 days ago
85%
Bearish Trend 2 days ago
90%
MACD
ODDS (%)
Bearish Trend 2 days ago
82%
Bearish Trend 2 days ago
90%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
84%
Bearish Trend 2 days ago
89%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
81%
Bullish Trend 2 days ago
78%
Advances
ODDS (%)
Bullish Trend 12 days ago
83%
Bullish Trend 9 days ago
82%
Declines
ODDS (%)
Bearish Trend 3 days ago
84%
Bearish Trend 3 days ago
86%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
81%
Bearish Trend 2 days ago
78%
Aroon
ODDS (%)
Bullish Trend 2 days ago
80%
Bullish Trend 2 days ago
79%
View a ticker or compare two or three
Interact to see
Advertisement
GTBIF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
TSNDF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
SWSSX38.660.19
+0.49%
Schwab Small Cap Index
NUGIX36.87N/A
N/A
Nuveen Global Dividend Growth I
TADFX8.47N/A
N/A
Transamerica Sustainable Equity Inc R6
ERBIX20.01N/A
N/A
Eaton Vance Equity Strategy I
CFJAX35.23N/A
N/A
Calvert US Large Cap Value Rspnb Idx A

GTBIF and

Correlation & Price change

A.I.dvisor indicates that over the last year, GTBIF has been closely correlated with CURLF. These tickers have moved in lockstep 82% of the time. This A.I.-generated data suggests there is a high statistical probability that if GTBIF jumps, then CURLF could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To GTBIF
1D Price
Change %
GTBIF100%
+4.55%
CURLF - GTBIF
82%
Closely correlated
+1.79%
TCNNF - GTBIF
82%
Closely correlated
+4.55%
VRNOF - GTBIF
79%
Closely correlated
+5.51%
TSNDF - GTBIF
77%
Closely correlated
+13.08%
CRLBF - GTBIF
71%
Closely correlated
+5.26%
More

TSNDF and

Correlation & Price change

A.I.dvisor indicates that over the last year, TSNDF has been closely correlated with GTBIF. These tickers have moved in lockstep 77% of the time. This A.I.-generated data suggests there is a high statistical probability that if TSNDF jumps, then GTBIF could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To TSNDF
1D Price
Change %
TSNDF100%
+13.08%
GTBIF - TSNDF
77%
Closely correlated
+4.55%
TCNNF - TSNDF
76%
Closely correlated
+4.55%
CRLBF - TSNDF
75%
Closely correlated
+5.26%
VRNOF - TSNDF
73%
Closely correlated
+5.51%
CURLF - TSNDF
73%
Closely correlated
+1.79%
More